Carisma Therapeutics Inc. (CARM) — Cash Flow Quality Index
Carisma Therapeutics Inc. (CARM) has a Cash Flow Quality Index of 0.04x as of September 2025. Operating cash flow of $1.91 Million is below net income of $44.72 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Carisma Therapeutics Inc. (CARM) cash conversion ratio to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Carisma Therapeutics Inc. Cash Flow Quality Index (2016–2016)
Historical Cash Flow Quality Index for Carisma Therapeutics Inc. across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check cash flow reinvestment rate of Carisma Therapeutics Inc. to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Carisma Therapeutics Inc. (2016–2016)
Year-by-year earnings quality comparison for Carisma Therapeutics Inc.. For live market cap and the full company financial profile, see Carisma Therapeutics Inc. stock valuation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2016 | 1.39x | $2.62 Million | $1.89 Million | — |